Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
10.53
+1.05 (11.08%)
At close: Aug 15, 2025, 4:00 PM
10.61
+0.08 (0.76%)
After-hours: Aug 15, 2025, 5:52 PM EDT
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $46.75 million as of August 15, 2025. Its market cap has increased by 20.60% in one year.
Market Cap
46.75M
Enterprise Value
41.94M
1-Year Change
20.60%
Ranking
Category
Stock Price
$10.53
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $46.75M, a decrease of -47.26%. That is a compound annual growth rate of -14.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 42.09M | 15.58% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
| Jun 28, 2021 | 88.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 614.44B |
| Johnson & Johnson | 420.78B |
| AbbVie | 361.58B |
| UnitedHealth Group | 245.88B |
| AstraZeneca | 240.81B |
| Novartis AG | 236.22B |
| Novo Nordisk | 225.09B |
| Abbott Laboratories | 225.01B |